 |
|
|
| |
Drug-Drug Interactions of Commonly Used Medications with Direct Acting Antiviral HCV Combination Therapy of Paritaprevir/r, Ombitasvir and Dasabuvir
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy Washington D.C., May 26-28, 2015
Akshanth R. Polepally, Jennifer R. King, Bifeng Ding, Diana L. Shuster, Emily O. Dumas, Amit Khatri, Jingtao Wu, Thomas J. Podsadecki, Rajeev M. Menon
Clinical Pharm of HIV & Hepatitis Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir: Drug Interactions with Antiretroviral Agents - (06/01/15)
Clinical Pharm of HIV & Hepatitis Possible Dose Adjustments With Four Drugs and Abbvie 3D HCV Regimen -- (06/01/15)
Clinical Pharm of HIV & Hepatitis Assessment of Drug-Drug Interactions Between Daclatasvir and Darunavir/Ritonavir or Lopinavir/Ritonavir - (06/03/15)
|
| |
|
|
|
|
|
